GILEAD SCIENCESGILEAD SCIENCESGILEAD SCIENCES

GILEAD SCIENCES

No trades
See on Supercharts
Market capitalization
‪75.30 B‬CHF
‪4.77 B‬CHF
‪22.78 B‬CHF
‪1.25 B‬
Beta (1Y)
0.47

About GILEAD SCIENCES

CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Employees (FY)
‪18 K‬
Founded
1987
ISIN
US3755581036
FIGI
BBG006TLQ7S4
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GILD is 66.00 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange GILEAD SCIENCES stocks are traded under the ticker GILD.
GILEAD SCIENCES is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
GILD stock is 0% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is GILEAD SCIENCES there?
One year price forecast for GILEAD SCIENCES has a max estimate of 109.53 CHF and a min estimate of 62.98 CHF.
GILD earnings for the last quarter are 2.10 CHF per share, whereas the estimation was 1.75 CHF resulting in a 19.50% surprise. The estimated earnings for the next quarter are 1.48 CHF per share. See more details about GILEAD SCIENCES earnings.
GILEAD SCIENCES revenue for the last quarter amounts to ‪6.46 B‬ CHF despite the estimated figure of ‪6.24 B‬ CHF. In the next quarter revenue is expected to reach ‪5.98 B‬ CHF.
Yes, you can track GILEAD SCIENCES financials in yearly and quarterly reports right on TradingView.
GILD net income for the last quarter is ‪1.20 B‬ CHF, while the quarter before that showed ‪2.00 B‬ CHF of net income which accounts for −39.72% change. Track more GILEAD SCIENCES financial stats to get the full picture.
Today GILEAD SCIENCES has the market capitalization of ‪75.30 B‬, it has decreased by 0.05% over the last week.
Yes, GILD dividends are paid quarterly. The last dividend per share was 0.68 CHF. As of today, Dividend Yield (TTM)% is 4.56%. Tracking GILEAD SCIENCES dividends might help you take more informed decisions.
GILEAD SCIENCES dividend yield was 3.70% in 2023, and payout ratio reached 66.62%. The year before the numbers were 3.40% and 80.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
GILD reached its all-time high on Aug 4, 2015 with the price of 116.40 CHF, and its all-time low was 62.20 CHF and was reached on May 22, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is GILEAD SCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GILEAD SCIENCES technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GILEAD SCIENCES stock shows the sell signal. See more of GILEAD SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GILEAD SCIENCES future price: according to them, GILD price has a max estimate of 109.53 CHF and a min estimate of 62.98 CHF. Read a more detailed GILEAD SCIENCES forecast: see what analysts think of GILEAD SCIENCES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES EBITDA is ‪10.00 B‬ CHF, and current EBITDA margin is 45.96%. See more stats in GILEAD SCIENCES financial statements.